Literature DB >> 28926134

Early genetic aberrations in patients with sporadic colorectal cancer.

Brooke R Druliner1, Xiaoyang Ruan2, Hugues Sicotte2, Daniel O'Brien2, Hongfang Liu2, Jean-Pierre A Kocher2, Lisa Boardman1.   

Abstract

Chromosome instability (CIN) is widely observed in both sporadic and hereditary colorectal cancer (CRC). Defects in APC and WNT signaling are primarily associated with CIN in hereditary CRC, but the genetic causes for CIN in sporadic CRC remain elusive. Using high-density SNP array and exome data from The Cancer Genome Atlas (TCGA), we characterized loss of heterozygosity (LOH) and copy number variation (CNV) in the peripheral blood, normal colon, and corresponding tumor tissue in 15 CRC patients with proficient mismatch repair (MMR) and 24 CRC patients with deficient MMR. We found a high frequency of 18q LOH in tumors and arm-specific enrichment of genetic aberrations on 18q in the normal colon (primarily copy neutral LOH) and blood (primarily copy gain). These aberrations were specific to the sporadic, pMMR CRC. Though in tumor samples genetic aberrations were observed for genes commonly mutated in hereditary CRC (eg, APC, CTNNB1, SMAD4, BRAF), none of them showed LOH or CNV in the normal colon or blood. DCC located on 18q21.1 topped the list of genes with genetic aberrations in the tumor. In an independent cohort of 13 patients subjected to Whole Genome Sequencing (WGS), we found LOH and CNV on 18q in adenomatous polyp and tumor tissues. Our data suggests that patients with sporadic CRC may have genetic aberrations preferentially enriched on 18q in their blood, normal colon epithelium, and non-malignant polyp lesions that may prove useful as a clinical marker for sporadic CRC detection and risk assessment.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CNV; LOH; colorectal cancer; genetic aberrations; neoplastic transformation

Mesh:

Year:  2017        PMID: 28926134      PMCID: PMC5716916          DOI: 10.1002/mc.22738

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  45 in total

1.  Deleted in Colorectal Cancer (DCC) encodes a netrin receptor.

Authors:  K Keino-Masu; M Masu; L Hinck; E D Leonardo; S S Chan; J G Culotti; M Tessier-Lavigne
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

Review 2.  The chromosomal instability pathway in colon cancer.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

3.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  The DCC gene: structural analysis and mutations in colorectal carcinomas.

Authors:  K R Cho; J D Oliner; J W Simons; L Hedrick; E R Fearon; A C Preisinger; P Hedge; G A Silverman; B Vogelstein
Journal:  Genomics       Date:  1994-02       Impact factor: 5.736

5.  Adenoma and carcinoma components in colonic tumors show discordance for KRAS mutation.

Authors:  Dov Hershkovitz; Einav Simon; Tova Bick; Elad Prinz; Shawna Noy; Edmond Sabo; Ofer Ben-Izhak; Michael Vieth
Journal:  Hum Pathol       Date:  2014-05-28       Impact factor: 3.466

Review 6.  Progressing toward a molecular description of colorectal cancer development.

Authors:  E R Fearon; P A Jones
Journal:  FASEB J       Date:  1992-07       Impact factor: 5.191

7.  Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.

Authors:  Claudia A L Ruivenkamp; Tom van Wezel; Carlo Zanon; Alphons P M Stassen; Cestmir Vlcek; Tamás Csikós; Anita M Klous; Nikos Tripodis; Anastassis Perrakis; Lucie Boerrigter; Peter C Groot; Jan Lindeman; Wolter J Mooi; Gerrit A Meijjer; Gert Scholten; Hans Dauwerse; Vaclav Paces; Nico van Zandwijk; Gert Jan B van Ommen; Peter Demant
Journal:  Nat Genet       Date:  2002-06-24       Impact factor: 38.330

8.  Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.

Authors:  Liping Luo; Gong-Qing Shen; Karen A Stiffler; Qing K Wang; Thomas G Pretlow; Theresa P Pretlow
Journal:  Carcinogenesis       Date:  2006-02-12       Impact factor: 4.944

Review 9.  The significance of unstable chromosomes in colorectal cancer.

Authors:  Harith Rajagopalan; Martin A Nowak; Bert Vogelstein; Christoph Lengauer
Journal:  Nat Rev Cancer       Date:  2003-09       Impact factor: 60.716

10.  Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location.

Authors:  Xiaoyang Ruan; Jean-Pierre A Kocher; Yves Pommier; Hongfang Liu; William C Reinhold
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

View more
  11 in total

1.  Analysis of KRAS, NRAS, and BRAF Mutations, Microsatellite Instability, and Relevant Prognosis Effects in Patients With Early Colorectal Cancer: A Cohort Study in East Asia.

Authors:  Yang Li; Jun Xiao; Tiancheng Zhang; Yanying Zheng; Hailin Jin
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

2.  DIP-microhaplotypes: new markers for detection of unbalanced DNA mixtures.

Authors:  Jinding Liu; Ting Hao; Xiaojuan Cheng; Jiaqi Wang; Wenyan Li; Zidong Liu; Jie Shi; Zeqin Li; Jianbo Ren; Keming Yun; Gengqian Zhang
Journal:  Int J Legal Med       Date:  2020-05-05       Impact factor: 2.686

Review 3.  Exploiting DNA repair defects in colorectal cancer.

Authors:  Nicole M Reilly; Luca Novara; Federica Di Nicolantonio; Alberto Bardelli
Journal:  Mol Oncol       Date:  2019-03-02       Impact factor: 6.603

4.  Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial‑mesenchymal transition.

Authors:  Zhenlv Lin; Lin Zhang; Junfeng Zhou; Jiantao Zheng
Journal:  Mol Med Rep       Date:  2019-08-21       Impact factor: 2.952

5.  RKDOSCNV: A Local Kernel Density-Based Approach to the Detection of Copy Number Variations by Using Next-Generation Sequencing Data.

Authors:  Guojun Liu; Junying Zhang; Xiguo Yuan; Chao Wei
Journal:  Front Genet       Date:  2020-11-04       Impact factor: 4.599

6.  Assessment of the Role of Selected SMAD3 and SMAD4 Genes Polymorphisms in the Development of Colorectal Cancer: Preliminary Research.

Authors:  Agnieszka Wosiak; Damian Wodziński; Katarzyna Michalska; Jacek Pietrzak; Radzisław Kordek; Ewa Balcerczak
Journal:  Pharmgenomics Pers Med       Date:  2021-01-29

7.  Clinical-grade whole-genome sequencing and 3' transcriptome analysis of colorectal cancer patients.

Authors:  Agata Stodolna; Miao He; Mahesh Vasipalli; Zoya Kingsbury; Jennifer Becq; Joanne D Stockton; Mark P Dilworth; Jonathan James; Toju Sillo; Daniel Blakeway; Stephen T Ward; Tariq Ismail; Mark T Ross; Andrew D Beggs
Journal:  Genome Med       Date:  2021-02-25       Impact factor: 11.117

8.  Genome-Wide Scan for Copy Number Alteration Association with Relapse-Free Survival in Colorectal Cancer with Liver Metastasis Patients.

Authors:  Po-Sheng Yang; Hsi-Hsien Hsu; Tzu-Chi Hsu; Ming-Jen Chen; Cin-Di Wang; Sung-Liang Yu; Yi-Chiung Hsu; Ker-Chau Li
Journal:  J Clin Med       Date:  2018-11-18       Impact factor: 4.241

9.  The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of CUL4A/4B and affects the stability of CRL4 E3 ligases in colorectal cancer.

Authors:  Wenzhu Lu; Chunmei Yang; Hongbo He; Hong Liu
Journal:  Int J Biol Sci       Date:  2020-02-04       Impact factor: 6.580

10.  Mutation Profiling of Premalignant Colorectal Neoplasia.

Authors:  Jakub Karczmarski; Krzysztof Goryca; Jacek Pachlewski; Michalina Dabrowska; Kazimiera Pysniak; Agnieszka Paziewska; Maria Kulecka; Malgorzata Lenarcik; Andrzej Mroz; Michal Mikula; Jerzy Ostrowski
Journal:  Gastroenterol Res Pract       Date:  2019-11-12       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.